Buying Zone: 319 | Stop-loss: Rs 306 | Target: Rs 342Prime Focus has staged a strong breakout above the key 315 resistance zone, indicating a continuation of its recent uptrend.
Vaishali Patel, Senior Manager - Research- Technical Department at JainamDisclosure: This article has been written by Podishetti Akash, who is not a SEBI-registered Research Analyst or an Investment Adviser.
The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution.
They should not be construed as the views or recommendations of The Economic Times Digital or the journalist.
Readers are advised to consider the original research report and make their investment decisions based on their own assessment.
Buying Zone: 319 | Stop-loss: Rs 306 | Target: Rs 342
Prime Focus has staged a strong breakout above the key 315 resistance zone, indicating a continuation of its recent uptrend. The stock has been forming a series of higher highs and higher lows and is comfortably trading above its 20-day, 50-day, and 100-day moving averages, reflecting strong trend strength. The breakout is supported by steady buying interest and improving price structure following a healthy consolidation phase.
Vaishali Patel, Senior Manager - Research- Technical Department at Jainam
Disclosure: This article has been written by Podishetti Akash, who is not a SEBI-registered Research Analyst or an Investment Adviser. Podishetti Akash and her ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclourses here.
